Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes

CONCLUSION: MMP9 may contribute to the initiation of atherosclerosis and may be a potential biomarker for the early identification of atherosclerosis in patients with diabetes.CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov, identifier NCT04424706.PMID:38660518 | PMC:PMC11039961 | DOI:10.3389/fendo.2024.1369369

Source: Atherosclerosis - April 25, 2024 Category: Cardiology Authors: Bingli Liu Liping Su Sze Jie Loo Yu Gao Ester Khin Xiaocen Kong Rinkoo Dalan Xiaofei Su Kok-Onn Lee Jianhua Ma Lei Ye Source Type: research